Retour
Fourchette du Jour
114,40 €
114,70 €
Fourchette 52 Semaines
47,86 €
114,91 €
Volume
1 377 509
Moyenne 50J / 200J
86,59 €
/
77,34 €
Clôture Précédente
114,60 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -29,3 | 0,3 |
| P/B | 16,7 | 2,9 |
| ROE % | -53,4 | 3,7 |
| Net Margin % | -1027,3 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
110,42 €
-3.7%
Low: 82,00 €
High: 120,00 €
BPA Prévisionnel
-3,52 €
CA Est.
87 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
3,87 €
1,35 € – 8,12 €
|
740 M | 4 |
| FY2028 |
0,33 €
-0,48 € – 1,22 €
|
460 M | 10 |
| FY2027 |
-1,61 €
-5,47 € – 1,86 €
|
270 M | 10 |
Points Clés
Debt/Equity of 0,24 — conservative balance sheet
Negative free cash flow of -212,59M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-79,35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-53,42%
ROIC-38,07%
Net Margin-1027,25%
Op. Margin-1135,61%
Sécurité
Debt / Equity
0,24
Current Ratio4,44
Interest Coverage-10,45
Valorisation
P/E Ratio
-29,30
P/B Ratio16,67
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -79,35% | Revenue Growth (3Y) | -55,05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 22,29M | Net Income (TTM) | -228,93M |
| ROE | -53,42% | ROA | -37,90% |
| Gross Margin | 70,03% | Operating Margin | -1135,61% |
| Net Margin | -1027,25% | Free Cash Flow (TTM) | -212,59M |
| ROIC | -38,07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,24 | Current Ratio | 4,44 |
| Interest Coverage | -10,45 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -29,30 | P/B Ratio | 16,67 |
| P/S Ratio | 300,95 | PEG Ratio | -0,15 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 6,71B | Enterprise Value | 6,72B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 22,29M | 107,94M | 110,32M | 0,0 | 0,0 |
| Net Income | -228,93M | -107,35M | -70,69M | -188,68M | -64,97M |
| EPS (Diluted) | -4,07 | -2,00 | -1,47 | -4,28 | -1,94 |
| Gross Profit | 15,61M | 102,75M | 110,32M | -2,22M | 0,0 |
| Operating Income | -253,08M | -137,57M | -89,88M | -191,26M | -65,02M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 603,99M | 711,33M | 825,13M | 313,82M | 128,78M |
| Total Liabilities | 201,64M | 256,54M | 339,75M | 108,86M | 250,30M |
| Shareholders' Equity | 402,35M | 454,79M | 485,38M | 204,95M | -121,52M |
| Total Debt | 96,26M | 54,08M | 97,63M | 88,13M | 0,0 |
| Cash & Equivalents | 80,26M | 105,68M | 394,58M | 64,18M | 30,83M |
| Current Assets | 462,18M | 599,31M | 716,36M | 266,86M | 112,81M |
| Current Liabilities | 104,20M | 125,41M | 118,24M | 56,69M | 14,85M |